2m 2m 2m 2m 2m 2m 2m
Ayr Wel-SV-RV-LV (AYRWF)
OTC
$0.02+$0.001 (+7.65%)
Price as of Jun 03, 2026- $2.4MMarket Cap
- -82.74%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Ayr Wel-SV-RV-LV (AYRWF)
$0.02+$0.001 (+7.65%)
Annual
Quarterly
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 463.6M +0.0006% | 463.6M -0.43% | 465.6M +30.20% | 357.6M +130.54% | |
Cost of Revenue | 287.0M +9.86% | 261.2M N/A | N/A N/A | N/A N/A | |
Gross Profit | 176.7M -12.73% | 202.4M +6.30% | 190.4M +37.91% | 138.1M +33.94% | |
Sales and Marketing Expense | 167.1M -6.00% | 177.8M -19.94% | 222.1M +2,784.32% | 7.7M +258.05% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 58.1M -0.98% | 58.6M N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 337.7M +40.90% | 239.7M +7.91% | 222.1M +62.41% | 136.7M +276.26% | |
Operating Profit | -161.0M +332.60% | -37.2M -84.69% | -243.0M +333.90% | -56.0M -447.50% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -78.3M +98.61% | -39.4M +28.87% | -30.6M +84.75% | -16.5M +302.11% | |
Interest Income and Expense and Net | -78.3M +98.61% | -39.4M +28.87% | -30.6M +84.75% | -16.5M +302.11% | |
Total Nonoperating Income and Expense | -158.1M +1,750.65% | -8.5M -127.94% | 30.6M +84.75% | 16.5M +302.11% | |
Income before Taxes | -319.1M +597.36% | -45.8M -82.09% | -255.5M +1,407.07% | -17.0M -90.39% | |
Income Taxes | 43.3M -8.69% | 47.4M +4.44% | 45.4M +55.07% | 29.3M +20.09% | |
Extraordinary Items | 118.1M +1,768.88% | 6.3M N/A | N/A N/A | N/A N/A | |
Net Income | -359.3M +31.89% | -272.4M +6.63% | -255.5M +1,407.07% | -17.0M -90.39% | |
Net Income from Continuing Operations Applicable to Common | -319.1M +597.36% | -45.8M -82.09% | -255.5M +1,407.07% | -17.0M -90.39% | |
Basic EPS and Net Income | -3.24 -11.96% | -3.68 +2.79% | -3.58 +1,093.33% | -0.30 N/A | |
Diluted EPS and Net Income | -3.24 -11.96% | -3.68 +2.79% | -3.58 +1,093.33% | -0.30 N/A | |
Basic Weighted Average Shares | 110,832 +49.58% | 74,096 +7.96% | 68,635 -99.88% | 57.3M +105.54% | |
Diluted Weighted Average Shares | 110,832 +49.58% | 74,096 +7.96% | 68,635 -99.88% | 57.3M +105.54% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 35.5M -30.11% | 50.8M -37.05% | 80.6M -47.75% | 154.3M +21.30% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 35.5M -30.11% | 50.8M -37.05% | 80.6M -47.75% | 154.3M +21.30% | |
Total Current Assets | 175.2M -9.35% | 193.2M -9.51% | 213.5M -19.75% | 266.1M +50.80% | |
Accumulated Depreciation | 53.4M +40.51% | 38.0M N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 277.7M -10.58% | 310.6M -4.99% | 326.9M +18.78% | 275.2M +298.27% | |
Total Long-Term Assets | 277.7M -10.58% | 310.6M +4,619.16% | 6.6M N/A | N/A N/A | |
Total Assets | 1.3B -13.06% | 1.5B -17.24% | 1.8B -5.16% | 1.9B +202.00% | |
Income Taxes Payable | 53.2M -65.71% | 155.0M N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 24.8M +7.24% | 23.2M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 109.3M -45.47% | 200.5M -12.45% | 229.0M +50.32% | 152.3M +163.76% | |
Total Long-Term Debt | 385.6M +130.44% | 167.4M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 22.0M -12.04% | 25.0M +2,680.96% | 898,000 -49.71% | 1.8M -98.82% | |
Total Liabilities | 904.3M +1.70% | 889.2M -4.24% | 928.6M +10.56% | 839.8M +80.61% | |
Retained Earnings | -1.1B +45.88% | -783.1M +53.35% | -510.7M +92.56% | -265.2M -37.13% | |
Total Stockholders Equity | 379.5M -34.76% | 581.8M -30.35% | 835.3M -18.11% | 1.0B +576.17% | |
Total Shares Outstanding | 0 -100.00% | 155.2M +10.33% | 140.7M +4.78% | 134.2M +287.58% | |
Cash Flow | |||||
Cash from Operating Activities | 9.6M -64.54% | 27.2M N/A | N/A N/A | N/A N/A | |
Capital Expenditures | 17.7M -36.04% | 27.7M N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -21.8M -9.68% | -24.2M -63.68% | -66.5M -69.72% | -219.6M +252.83% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -3.1M -90.57% | -32.9M -221.98% | 27.0M -90.18% | 274.5M +89.88% | |
Financials Ratio | |||||
Gross Margin | 38.11% -12.73% | 43.66% N/A | N/A N/A | N/A N/A | |
Operating Margin | -34.72% +332.60% | -8.03% -84.62% | -52.19% +233.25% | -15.66% N/A | |
Return on Assets | -26.33% +55.80% | -16.90% +19.87% | -14.10% +929.60% | -1.37% N/A | |
Return on Equity | -74.75% +94.42% | -38.45% +39.61% | -27.54% +851.09% | -2.90% N/A | |
Revenue Growth | 0.0006% +100.14% | -0.43% -101.41% | 30.20% -76.86% | 130.54% N/A | |
Current Ratio | 1.60 +66.24% | 0.96 +3.36% | 0.93 -46.61% | 1.75 N/A | |
Cash Ratio | 0.32 +28.20% | 0.25 -28.09% | 0.35 -65.25% | 1.01 N/A | |
Debt-to-Equity Ratio | 1.08 +230.33% | 0.33 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.32 +147.82% | 0.13 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow